AI assistant
Orkla ASA — Share Issue/Capital Change 2014
Sep 29, 2014
3703_iss_2014-09-29_980c0054-0241-441d-8a57-4d141f7a95ee.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Orkla ASA : Orkla annonserer børsnotering av Gränges. Aksjene forventes å bli notert på NASDAQ OMX Stockholm den 10. oktober
Orkla ASA : Orkla annonserer børsnotering av Gränges. Aksjene forventes å bli notert på NASDAQ OMX Stockholm den 10. oktober
IKKE FOR DISTRIBUSJON ELLER OFFENTLIGGJØRING, DIREKTE ELLER INDIREKTE, I USA,
CANADA, JAPAN ELLER AUSTRALIA.
Det vises til børsmelding fra Orkla den 10. september 2014 vedrørende
intensjonen om å børsnotere Gränges AB (publ) ("Gränges") på NASDAQ OMX
Stockholm, herunder Orklas planlagte salg av aksjer i Gränges gjennom et
offentlig tilbud ("Tilbudet"). Orkla har nå besluttet å lansere Tilbudet. Under
forutsetning av at Tilbudet gjennomføres som planlagt, forventes det at aksjene
i Gränges vil bli tatt opp til notering på NASDAQ OMX Stockholm den 10. oktober
Peter A. Ruzicka, konsernsjef i Orkla sier:
"I tråd med Orklas langsiktige strategi om å være et rendyrket merkevareselskap,
har vi besluttet å invitere andre investorer til å ta del i Gränges' videre
utvikling. Vi tror at en børsnotering av Gränges vil gi selskapet økt strategisk
og operasjonell fleksibilitet. En bredere eierbase kommer til å gi Gränges
tilgang til svenske og internasjonale kapitalmarkeder, og dermed bidra til
selskapets videre vekst og utvikling."
Kort om tilbudet
* Orkla Industriinvesteringar AB, et heleid datterselskap av Orkla ASA, er
selger av aksjene.
* Tilbudet rettes mot allmennheten i Sverige og Norge samt mot institusjonelle
investorer.
* Tilbudet omfatter 44,8 millioner aksjer i Gränges, tilsvarende 60 prosent av
totalt antall aksjer i selskapet.
* Orkla har forbeholdt seg retten til å utvide Tilbudet ved å selge opp til
ytterligere 9,0 millioner aksjer, tilsvarende 12 prosent av totalt antall
aksjer i selskapet. I tillegg har Orkla tildelt dets finansielle rådgivere
en opsjon til å selge inntil 8,1 millioner aksjer, tilsvarende opp til 15
prosent av totalt antall aksjer i Tilbudet (ca 11 prosent av totalt antall
aksjer i selskapet).
* Dersom Orkla velger å utvide Tilbudet fullt ut samt at opsjonen gitt de
finansielle rådgiverne blir benyttet i sin helhet, vil Tilbudet omfatte
totalt 61,8 millioner aksjer, tilsvarende ca 83 prosent av totalt antall
aksjer i selskapet.
* Det forventes at endelig pris for aksjene vil ligge i intervallet SEK 42-50
per aksje ("Tilbudsprisen"), tilsvarende en markedsverdi for alle aksjer
utstedt av Gränges på omtrent SEK 3,1 - 3,7 milliarder. Tilbudsprisen
forventes å bli annonsert 10. oktober 2014.
* Prospekt med fullstendige vilkår er offentliggjort i dag 29. september 2014
på Orklas nettsider www.orkla.no og Gränges' nettsider www.granges.com.
For ytterligere informasjon om Tilbudet, vennligst se vedlagt pressemelding fra
Gränges.
Indikativ fremdriftsplan
30. september - 8. oktober 2014 Tegningsperiode for allmennheten i
Sverige og Norge
30. september - 9. oktober 2014 Bookbuilding-periode for
institusjonelle investorer
10. oktober 2014 Offentliggjøring av
endelig tilbudspris
10. oktober 2014 Første handelsdag
for aksjene på NASDAQ OMX Stockholm
14. oktober 2014 Oppgjør
Det gjøres oppmerksom på at norske og svenske aksjonærer i Orkla som er
registrert i aksjeeierboken per 25. september 2014, og som tegner seg for aksjer
i Tilbudet rettet mot allmennheten, kan gis prioritering i tildelingsprosessen.
Allmennheten i Norge kan kun tegne seg for aksjer i Tilbudet gjennom Nordnet
(www.nordnet.no). For ytterligere informasjon om prosedyren for tegning av
aksjer, henvises det til prospektet og tegningsskjemaer.
Carnegie og SEB er Joint Global Coordinators og Joint Bookrunners i forbindelse
med Tilbudet. Danske Bank og Handelsbanken Capital Markets er også Joint
Bookrunners.
Orkla ASA,
Oslo, 29. september 2014
For ytterligere informasjon, vennligst kontakt:
Rune Helland, SVP Investor Relations
Tel: +47 97 71 32 50
About Gränges
Gränges is a leading global supplier of rolled products for brazed aluminium
heat exchangers used primarily in automotive applications. The Company develops,
produces and markets materials that enhance both the production economy during
the customer manufacturing process as well as the performance of the final
products, the brazed heat exchangers. Gränges' vision is to help create smaller,
lighter and more designable heat exchangers to increase economic efficiency and
reduce environmental impact. Gränges operates through three geographical
regions: Europe, Asia and Americas with production, research and development in
Finspång, Sweden, and Shanghai, China. Through sales and technical support
offices in the U.S., India, Japan, South Korea and an agent in Brazil, the
Company serves customers worldwide. Gränges has a global leading position in its
market niche with an estimated total market share of approximately 20 per cent.
A short summary of Gränges' financial performance is provided below.
---------------------------------------+---------+---------+-------+-------
| H1 2014 | H1 2013 | 2013 | 2012
---------------------------------------+---------+---------+-------+-------
Net sales (SEKm) | 2,333 | 2,473 | 4,642 | 4,946
---------------------------------------+---------+---------+-------+-------
Sales volume (ktonnes) | 83.1 | 81.8 | 158.6 | 151.7
---------------------------------------+---------+---------+-------+-------
Adjusted operating profit 1. (SEKm) | 254 | 189 | 371 | 362
---------------------------------------+---------+---------+-------+-------
Adjusted operating profit margin (%) | 10.9% | 7.6% | 8.0% | 7.3%
---------------------------------------+---------+---------+-------+-------
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO
THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
DISCLAIMERS
This announcement is not an offer to buy any securities issued by Gränges AB
(publ) (the "Company") in any jurisdiction where such offer or sale would be
unlawful.
In any EEA Member State, other than Sweden and Norway, that has implemented
Directive2003/71/EC as amended (together with any applicable implementing
measures in any member State, the "Prospectus Directive"), this communication is
only addressed to and is only directed at qualified investors in that Member
State within the meaning of the Prospectus Directive.
This document and the information contained herein are not for distribution in
or into the United States of America. This document does not constitute an offer
to sell, or a solicitation of an offer to purchase, any securities in the United
States. Any securities referred to herein have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the "Securities
Act"), and may not be offered or sold within the United States absent
registration or an applicable exemption from, or in a transaction not subject
to, the registration requirements of the Securities Act. There is no intention
to register any securities referred to herein in the United States or to make a
public offering of the securities in the United States.
In the United Kingdom, this document and any other materials in relation to the
securities described herein is only being distributed to, and is only directed
at, and any investment or investment activity to which this document relates is
available only to, and will be engaged in only with, "qualified investors" (as
defined in section 86(7) of the Financial Services and Markets Act 2000) and who
are (i) persons having professional experience in matters relating to
investments who fall within the definition of "investment professionals" in
Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling
within Article 49(2)(a) to (d) of the Order (all such persons together being
referred to as "relevant persons"). Persons who are not relevant persons should
not take any action on the basis of this document and should not act or rely on
it.
Any offering of securities will be made by means of a prospectus that may be
obtained from the issuer or selling security holder and that will contain
detailed information about the Company and management, as well as financial
statements. This document is an advertisement and not a prospectus for the
purposes of the Prospectus Directive. Investors should not subscribe for any
securities referred to in this document except on the basis of information
contained in the prospectus.
Matters discussed in this release may constitute forward-looking statements.
Forward-looking statements are statements that are not historical facts and may
be identified by words such as "believe," "expect," "anticipate," "intends,"
"estimate," "will," "may," "continue," "should" and similar expressions. The
forward-looking statements in this release are based upon various assumptions,
many of which are based, in turn, upon further assumptions. Although the
Company believes that these assumptions were reasonable when made, these
assumptions are inherently subject to significant known and unknown risks,
uncertainties, contingencies and other important factors which are difficult or
impossible to predict and are beyond its control. Such risks, uncertainties,
contingencies and other important factors could cause actual events to differ
materially from the expectations expressed or implied in this release by such
forward-looking statements.
The information, opinions and forward-looking statements contained in this
release speak only as at its date, and are subject to change without notice.
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
--------------------------------------------------------------------------------
1. Operating profit adjusted for other income and expenses.
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12
[HUG#1859225]